Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Comment by TanzaniteMotherLodeon Jul 13, 2020 4:44am
45 Views
Post# 31258972

RE:RE:Commercial Launch is here!

RE:RE:Commercial Launch is here!

Infectious disease outbreaks will occur again in our lifetime. LexaGene’s open-access instrument can be rapidly configured to detect novel pathogens for use in preventing a pandemic by containing the spread quickly after a new pathogen emerges.

LexaGene’s MiQLab™ open-access diagnostic analyzer is ideally suited for preventing such a catastrophe, whether it is caused by influenza, coronavirus, or any other pathogen. In the event of another pandemic, the best way to minimize deaths is to quickly place infected individuals into quarantine. However, such decisions are more easily made if rapid and accurate diagnostics are available at the point-of-need to conclusively determine whether quarantine is required.

<< Previous
Bullboard Posts
Next >>